Announcement
06 Feb 2018
In February 2018, the European Investment Bank (EIB) signed a loan agreement with Aerogen to support its investments in developing new medical technologies related to aerosol drug delivery. The loan will be guaranteed by the European Fund for Strategic Investment (EFSI).
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
06 Feb 2019
Revocation date:
No revocation date
Updated: 06 Feb 2018
State loan
In force
The EIB's loan to Aerogen signed on 6 February 2019 was issued under the European Fund for Strategic Investment (EFSI). The loan has a total value of EUR 30 million (approx. USD 37 million) and wil...
Sign in to see more
Updated: 06 Feb 2018
State loan
In force
On 6 February 2019, the European Investment Bank (EIB) and Aerogen signed a loan agreement having a total value of EUR 30 million (approx. USD 37 million). The loan will support...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.